Acute stress differently modulates beta 1, beta 2 and beta 3 adrenoceptors in T cells, but not in B cells, from the rat spleen

NeuroImmunoModulation

Volumn 19, Issue 2, 2012, Pages 69-78

  Laukova, Marcela ^a   Vargovic, Peter ^a   Csaderova, Lucia ^c   Chovanova, Lucia ^a   Vlcek, Miroslav ^a   Imrich, Richard ^c   Krizanova, Olga ^b   Kvetnansky, Richard ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Adrenergic receptors; Apoptosis; B cells; Spleen; Stress; T cells

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

ACUTE STRESS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; IMMOBILIZATION STRESS; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; B-LYMPHOCYTES; CELL MEMBRANE; CELL NUCLEUS; MALE; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; SPLEEN; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES;

EID: 84856058058     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000329002     Document Type: Article

References (45)

1. Dhabhar FS: Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immuno-pathology. Neuroimmunomodulation 2009; 16: 300-317.
2. Calcagni E, Elenkov I: Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann NY Acad Sci 2006; 1069: 62-76. (Pubitemid 43989851)
3. Kohut ML, Martin AE, Senchina DS, Lee W: Glucocorticoids produced during exercise may be necessary for optimal virus-induced IL-2 and cell proliferation whereas both catecholamines and glucocorticoids may be required for adequate immune defense to viral infection. Brain Behav Immun 2005; 19: 423-435. (Pubitemid 41074781)
4. Dhabhar FS, Saul AN, Daugherty C, Holmes TH, Bouley DM, Oberyszyn TM: Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma. Brain Behav Immun 2010; 24:127-137.
5. O'Donnell PM, Orshal JM, Sen D, Sonnen-feld G, Aviles HO: Effects of exposure of mice to hindlimb unloading on leukocyte subsets and sympathetic nervous system activity. Stress 2009; 12: 82-88.
6. Rinner I, Schauenstein K, Mangge H, Porta S, Kvetnansky R: Opposite effects of mild and severe stress on in vitro activation of rat peripheral blood lymphocytes. Brain Behav Immun 1992; 6: 130-140.
7. Sudo N, Yu XN, Sogawa H, Kubo C: Restraint stress causes tissue-specific changes in the immune cell distribution. Neuroimmunomodulation 1997; 4:113-119. (Pubitemid 28093993)
8. 2-and a2C-adrenergic receptors and up-regulates gene expression of IL-6 in the rat spleen. Cell Mol Neurobiol 2010; 30:1077-1087.
9. Jelokova J, Rusnak M, Kubovcakova L, Buck-endahl P, Krizanova O, Sabban EL, Kvetnansky R: Stress increases gene expression of phenylethanolamine N-methyltransferase in spleen of rats via pituitary-adrenocorti-cal mechanism. Psychoneuroendocrinology 2002; 27:619-633. (Pubitemid 34310623)
10. Kubovcakova L, Micutkova L, Sabban EL, Krizanova O, Kvetnansky R: Identification of tyrosine hydroxylase gene expression in rat spleen. Neurosci Lett 2001; 310:157-160. (Pubitemid 32822828)
11. Xie Y, Frede S, Harnish MJ, Exton MS, Schedlowski M: Beta-adrenoceptor- induced inhibition of rat splenocyte proliferation: cytokine gene transcription as the target of action. Immunobiology 2002; 206:345-353. (Pubitemid 35256192)
12. Sanders VM, Straub RH: Norepinephrine, the fS-adrenergic receptor, and immunity. Brain Behav Immun 2002; 16:290-332.
13. Kohm AP, Sanders VM: Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 2001; 53: 487-525. (Pubitemid 33138209)
14. Emeny RT, Gao D, Lawrence DA: Beta1-ad-renergic receptors on immune cells impair innate defenses against Listeria. J Immunol 2007; 17 8: 4876-4884. (Pubitemid 46595269)
15. 125 I-iodocyanopindolol. Equine Ve t J 2001; 33:487-493. (Pubitemid 33662405)
16. Agüero J, Almenar L, D'Ocon P, Oliver E, Montó F, Rueda J, Vicente D, Martínez-Dolz L, Salvador A: Myocardial and peripheral lymphocytic transcriptomic dissociation of beta-adrenoceptors and G protein-coupled receptor kinases in heart transplantation. J Heart Lung Transplant 20 09; 28: 116 6-117 1.
17. Freier E, Weber CS, Nowottne U, Horn C, Bartels K, Meyer S, Hildebrandt Y, Luetkens T, Cao Y, Pabst C, Muzzulini J, Schnee B, Brunner-Weinzierl MC, Marangolo M, Bo-kemeyer C, Deter HC, Atanackovic D: Dec re a se of C D 4 (+)FOX P3(+) T reg u la tor y cel l s in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuro-endocrinolog y 2010; 35: 663-673.
18. Yu XY, Lin SG, Wang XM, Liu Y, Zhang B, Lin QX, Yang M, Zhou SF: Evidence for coexistence of three beta-adrenoceptor subtypes in human peripheral lymphocytes. Clin Pharmacol Ther 20 07; 8 1: 654-658. (Pubitemid 46625115)
19. Oliver E, Rovira E, Montó F, Valldecabres C, Julve R, Muedra V, Ruiz N, Barettino D, D'Ocon P: Beta-adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion. J Hypertens 2010; 28:1281-1289.
20. Lamas O, Martínez JA, Marti A: Effects of a beta3-adrenergic agonist on the immune response in diet-induced (cafeteria) obese animals. J Physiol Biochem 2003; 59: 183-191.
21. Borger P, Hoekstra Y, Esselink MT, Postma DS, Zaagsma J, Vellenga E, Kauffman HF: Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adreno-ceptor subtype. Am J Respir Cell Mol Biol 1998; 19: 400-407. (Pubitemid 128354209)
22. Lencesova L, Sirova M, Csaderova L, Lauko-va M, Sulova Z, Kvetnansky R, Krizanova O: Changes and role of adrenoceptors in PC12 cells after phenylephrine administration and apoptosis induction. Neurochem Int 2010; 57: 884-892.
23. Jiang J-L, Peng Y-P, Qiu Y-H, Wang J-J: Adr-enoreceptor-coupled signal-transduction mechanisms mediating lymphocyte apopto-sis induced by endogenous catecholamines. J Neuroimmunol 2009; 213:100-111.
24. Kvetnansky R, Mikulaj L: Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress. Endocrinology 1970; 87:738-743.
25. Leong DT, Gupta A, Bai HF, Wan G, Yoong LF: Absolute quantification of gene expression in biomaterials research using real-time PCR. Biomaterials 2007; 28:203-210. (Pubitemid 44537394)
26. Kitamura H, Shiva D, Woods JA, Yano H: Beta-adrenergic receptor blockade attenuates the exercise-induced suppression of TNF-alpha in response to lipopolysaccha-ride in rats. Neuroimmunomodulation 2007; 14:91-96. (Pubitemid 47442987)
27. Manni M, Maestroni GJ: Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: involvement of beta-adrenoceptors and relevance in inflammatory diseases. Brain Behav Immun 2008; 22:80-88. (Pubitemid 350225651)
28. Jain FA, Zhao L, Selig MK, Kradin RL: Epinephrine promotes pulmonary angiitis: evidence for a beta1-adrenoreceptor-mediated mechanism. Am J Physiol Lung Cell Mol Physiol 2003; 285:L232-L239. (Pubitemid 36736486)
29. Graafsma SJ, Hectors MP, van Tits LJ, Ro-drigues de Miranda JF, Thien T: The relationship between adrenaline and beta2-ad-renoceptors on human lymphocytes. Br J Clin Pharmacol 1990; 30:145S-147S. (Pubitemid 20331149)
30. Murray DR, Irwin M, Rearden CA, Ziegler M, Motulsky H, Maisel AS: Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic-de-pendent mechanism. Circulation 1992; 86: 203-213.
31. Germack R, Dickenson JM: Induction of be-ta3-adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes. J Pharmacol Exp Ther 2006; 316: 392-402. (Pubitemid 41832619)
32. Mann DL, Cooper G: Neurohumoral activation in congestive heart failure: a double-edged sword? Clin Cardiol 1989; 12:485-490. (Pubitemid 19229199)
33. Champlain J, Farley L, Cousineau D, van Ameringen MR: Circulating catecholamine levels in human and experimental hypertension. Circ Res 1976; 38:109-114.
34. Qu LL, Guo NN, Li BM: Beta1-and beta2-adrenoceptors in basolateral nucleus of amygdala and their roles in consolidation of fear memory in rats. Hippocampus 2008; 18: 1131-1139.
35. 1-and -adrenoceptors in the CA1 and CA3 regions of the rat hippocampus. Neuroscience 2007; 146: 298-305.
36. Anderson GP: Current issues with -adrenoceptor agonists: pharmacology and molecular and cellular mechanisms. Clin Rev Allergy Immunol 2006; 31:119-130. (Pubitemid 44804943)
37. 2-adrenergic receptor subtypes optimizes fS-adrenergic modulation of cardiac contractility. Circ Res 2005; 97: 244-251. (Pubitemid 41105450)
38. 3-adrenergic receptors generates a fS-adrenergic signaling unit with distinct functional properties. J Biol Chem 2004; 279: 28756-28765. (Pubitemid 38900160)
39. Marshall GD Jr, Agarwal SK: Stress, immune regulation, and immunity: applications for asthma. Allergy Asthma Proc 2000; 21: 241-246.
40. Kubera M, Holan V, Basta-Kaim A, Roman A, Borycz J, Shani J: Effect of desipramine on immunological parameters in mice, and their reversal by stress. Int J Immunophar-macol 1998; 20:429-438. (Pubitemid 29034726)
41. Cheung DL, Hart PH, Vitti GF, Whitty GA, Hamilton JA: Contrasting effect of interferon-7 and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 1990; 71: 70-75. (Pubitemid 20296074)
42. te Velde AA, Huijbens RJF, Heije K, de Vries JE, Figdor CG: Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 1990; 76: 1392-1397. (Pubitemid 20342757)
43. Feldman RD, Hunninghake GW, McArdle WL: fS-Adrenergic receptor-mediated suppression of interleukin-2 receptors in human lymphocytes. J Immunol 1987; 139: 3355-3359. (Pubitemid 18021987)
44. Sancho D, Gómez M, Sánchez-Madrid F: CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005; 26: 136-140. (Pubitemid 40312520)
45. Liebig TM, Fiedler A, Klein-Gonzalez N, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M: Murine model of CD40-activation of B cells. J Vis Exp 2010;pii:1734.